Effects of ergonovine-induced vasoconstriction on the genesis of myocardial ischemia during coronary stenosis in dogs. 1983

S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki

We developed a canine model with coronary stenosis produced by intraluminal obstruction with a micro-balloon occluder to assess the role of vasomotor tone of a large coronary artery with a preexisting fixed stenosis in the genesis of myocardial ischemia. Hemodynamic and electrocardiographic responses to ergonovine, an agent capable of provoking coronary spasm, were evaluated. In the absence of coronary stenosis, intracoronary infusion of 4 micrograms/min ergonovine had no systemic and coronary hemodynamic effects. Similarly, with various degrees of external obstruction created by a screw-type metal constrictor, ergonovine had little hemodynamic effects. By contrast, with a stenosis greater than 28.4 +/- 5.0 mmHg in pressure gradient, created by intraluminal obstruction which preserved active arterial vasomotion, ergonovine-induced vasoconstriction produced a marked decrease in coronary blood flow and distal coronary pressure, followed by ST-elevation. These deleterious effects of ergonovine on coronary hemodynamics were reversed completely by intracoronary infusion of nitroglycerin. Our results indicate that the effects of normal coronary arterial vasomotor activity on a stenosed vessel can cause myocardial ischemia.

UI MeSH Term Description Entries
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003251 Constriction, Pathologic The condition of an anatomical structure's being constricted beyond normal dimensions. Stenosis,Stricture,Constriction, Pathological,Pathologic Constriction,Constrictions, Pathologic,Pathologic Constrictions,Pathological Constriction,Stenoses,Strictures
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004874 Ergonovine An ergot alkaloid (ERGOT ALKALOIDS) with uterine and VASCULAR SMOOTH MUSCLE contractile properties. Ergometrine,Ergonovine Maleate,Ergobasin,Ergometrin,Ergometrine Maleate,Ergotrate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014661 Vasoconstriction The physiological narrowing of BLOOD VESSELS by contraction of the VASCULAR SMOOTH MUSCLE. Vasoconstrictions

Related Publications

S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
June 1991, American heart journal,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
April 1984, Circulation,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
December 1997, European heart journal,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
January 1987, Journal of cardiovascular pharmacology,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
September 1996, The Journal of pharmacology and experimental therapeutics,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
July 1984, Naunyn-Schmiedeberg's archives of pharmacology,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
November 1983, Circulation,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
June 1991, Circulation,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
June 1997, Circulation,
S Sakamoto, and M Yokoyama, and H Akita, and S Kawashima, and T Okada, and T Mizutani, and H Fukuzaki
October 1992, Circulation research,
Copied contents to your clipboard!